Exploration of common pathogenic genes between cerebral amyloid angiopathy and insomnia based on bioinformatics and experimental validation

Abstract Cerebral amyloid angiopathy (CAA) and insomnia are age-related neurological disorders increasingly recognized as being closely associated. However, research on the shared genes and their biological mechanisms remains limited. This study aims to identify common genes between CAA and insomnia...

Full description

Saved in:
Bibliographic Details
Main Authors: Xin-Yu Li, Kun Li, Yi-Han Wei, Wen-Kai Yu, Jing-Hao Wu, Kai Gao, Wen-Jun He, Peng-Peng Niu, Chan Zhang, Yu-Nan Cheng, Yu-Sheng Li
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-12553-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849766930025545728
author Xin-Yu Li
Kun Li
Yi-Han Wei
Wen-Kai Yu
Jing-Hao Wu
Kai Gao
Wen-Jun He
Peng-Peng Niu
Chan Zhang
Yu-Nan Cheng
Yu-Sheng Li
author_facet Xin-Yu Li
Kun Li
Yi-Han Wei
Wen-Kai Yu
Jing-Hao Wu
Kai Gao
Wen-Jun He
Peng-Peng Niu
Chan Zhang
Yu-Nan Cheng
Yu-Sheng Li
author_sort Xin-Yu Li
collection DOAJ
description Abstract Cerebral amyloid angiopathy (CAA) and insomnia are age-related neurological disorders increasingly recognized as being closely associated. However, research on the shared genes and their biological mechanisms remains limited. This study aims to identify common genes between CAA and insomnia and explore their potential molecular mechanisms, offering new insights for diagnosis and treatment. Blood samples were collected from 11 CAA patients and 11 healthy controls, followed by RNA sequencing (RNA-seq). Additionally, the microarray dataset GSE208668 for the insomnia cohort was downloaded from the Gene Expression Omnibus (GEO) database. Differential expression analysis was performed to identify common differentially expressed genes (DEGs). Protein-protein interaction (PPI) networks and machine learning methods Random Forest (RF) and Extreme Gradient Boosting (XGBoost) were used to narrow down key genes. We explored the biological functions of these genes through immune cell infiltration, metabolic and Hallmark pathway analyses, and clinical correlation analysis. Co-expression networks, drug-mRNA networks, transcription factor (TF)–mRNA–miRNA networks, and competing endogenous RNA (ceRNA) networks were also constructed. Finally, hub gene expression patterns were analyzed using the Human Protein Atlas (HPA) database, and validation was performed in clinical samples and animal models using quantitative Reverse Transcription Polymerase Chain Reaction (qRT-PCR) and Western blot. Differential expression analysis identified 185 DEGs. PPI network construction and machine learning methods identified CBX5 and POLR1B as common hub genes for both insomnia and CAA. Immune infiltration, metabolic, and Hallmark pathway analyses revealed these hub genes play distinct roles in each disease. Various network models were constructed to explore their regulatory mechanisms. The reliability of the hub genes was validated using bioinformatics analyses and experimental approaches. This study, combining bioinformatics and experimental validation, identifies CBX5 and POLR1B as shared hub genes for CAA and insomnia. These findings offer new molecular targets for the diagnosis and treatment of both diseases, providing a foundation for future research.
format Article
id doaj-art-04c1c91acb164f5cafca599a714f4f21
institution DOAJ
issn 2045-2322
language English
publishDate 2025-07-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-04c1c91acb164f5cafca599a714f4f212025-08-20T03:04:25ZengNature PortfolioScientific Reports2045-23222025-07-0115111710.1038/s41598-025-12553-yExploration of common pathogenic genes between cerebral amyloid angiopathy and insomnia based on bioinformatics and experimental validationXin-Yu Li0Kun Li1Yi-Han Wei2Wen-Kai Yu3Jing-Hao Wu4Kai Gao5Wen-Jun He6Peng-Peng Niu7Chan Zhang8Yu-Nan Cheng9Yu-Sheng Li10Department of Neurology, the First Affiliated Hospital of Zhengzhou UniversityDepartment of Neurology, the First Affiliated Hospital of Zhengzhou UniversityDepartment of Neurology, the First Affiliated Hospital of Zhengzhou UniversityDepartment of Neurology, the First Affiliated Hospital of Zhengzhou UniversityDepartment of Neurology, the First Affiliated Hospital of Zhengzhou UniversityDepartment of Neurology, the First Affiliated Hospital of Zhengzhou UniversityDepartment of Neurology, the First Affiliated Hospital of Zhengzhou UniversityDepartment of Neurology, the First Affiliated Hospital of Zhengzhou UniversityDepartment of Neurology, the First Affiliated Hospital of Zhengzhou UniversityDepartment of Neurology, the First Affiliated Hospital of Zhengzhou UniversityDepartment of Neurology, the First Affiliated Hospital of Zhengzhou UniversityAbstract Cerebral amyloid angiopathy (CAA) and insomnia are age-related neurological disorders increasingly recognized as being closely associated. However, research on the shared genes and their biological mechanisms remains limited. This study aims to identify common genes between CAA and insomnia and explore their potential molecular mechanisms, offering new insights for diagnosis and treatment. Blood samples were collected from 11 CAA patients and 11 healthy controls, followed by RNA sequencing (RNA-seq). Additionally, the microarray dataset GSE208668 for the insomnia cohort was downloaded from the Gene Expression Omnibus (GEO) database. Differential expression analysis was performed to identify common differentially expressed genes (DEGs). Protein-protein interaction (PPI) networks and machine learning methods Random Forest (RF) and Extreme Gradient Boosting (XGBoost) were used to narrow down key genes. We explored the biological functions of these genes through immune cell infiltration, metabolic and Hallmark pathway analyses, and clinical correlation analysis. Co-expression networks, drug-mRNA networks, transcription factor (TF)–mRNA–miRNA networks, and competing endogenous RNA (ceRNA) networks were also constructed. Finally, hub gene expression patterns were analyzed using the Human Protein Atlas (HPA) database, and validation was performed in clinical samples and animal models using quantitative Reverse Transcription Polymerase Chain Reaction (qRT-PCR) and Western blot. Differential expression analysis identified 185 DEGs. PPI network construction and machine learning methods identified CBX5 and POLR1B as common hub genes for both insomnia and CAA. Immune infiltration, metabolic, and Hallmark pathway analyses revealed these hub genes play distinct roles in each disease. Various network models were constructed to explore their regulatory mechanisms. The reliability of the hub genes was validated using bioinformatics analyses and experimental approaches. This study, combining bioinformatics and experimental validation, identifies CBX5 and POLR1B as shared hub genes for CAA and insomnia. These findings offer new molecular targets for the diagnosis and treatment of both diseases, providing a foundation for future research.https://doi.org/10.1038/s41598-025-12553-yCerebral amyloid angiopathyInsomniaBioinformaticsImmune cell infiltration
spellingShingle Xin-Yu Li
Kun Li
Yi-Han Wei
Wen-Kai Yu
Jing-Hao Wu
Kai Gao
Wen-Jun He
Peng-Peng Niu
Chan Zhang
Yu-Nan Cheng
Yu-Sheng Li
Exploration of common pathogenic genes between cerebral amyloid angiopathy and insomnia based on bioinformatics and experimental validation
Scientific Reports
Cerebral amyloid angiopathy
Insomnia
Bioinformatics
Immune cell infiltration
title Exploration of common pathogenic genes between cerebral amyloid angiopathy and insomnia based on bioinformatics and experimental validation
title_full Exploration of common pathogenic genes between cerebral amyloid angiopathy and insomnia based on bioinformatics and experimental validation
title_fullStr Exploration of common pathogenic genes between cerebral amyloid angiopathy and insomnia based on bioinformatics and experimental validation
title_full_unstemmed Exploration of common pathogenic genes between cerebral amyloid angiopathy and insomnia based on bioinformatics and experimental validation
title_short Exploration of common pathogenic genes between cerebral amyloid angiopathy and insomnia based on bioinformatics and experimental validation
title_sort exploration of common pathogenic genes between cerebral amyloid angiopathy and insomnia based on bioinformatics and experimental validation
topic Cerebral amyloid angiopathy
Insomnia
Bioinformatics
Immune cell infiltration
url https://doi.org/10.1038/s41598-025-12553-y
work_keys_str_mv AT xinyuli explorationofcommonpathogenicgenesbetweencerebralamyloidangiopathyandinsomniabasedonbioinformaticsandexperimentalvalidation
AT kunli explorationofcommonpathogenicgenesbetweencerebralamyloidangiopathyandinsomniabasedonbioinformaticsandexperimentalvalidation
AT yihanwei explorationofcommonpathogenicgenesbetweencerebralamyloidangiopathyandinsomniabasedonbioinformaticsandexperimentalvalidation
AT wenkaiyu explorationofcommonpathogenicgenesbetweencerebralamyloidangiopathyandinsomniabasedonbioinformaticsandexperimentalvalidation
AT jinghaowu explorationofcommonpathogenicgenesbetweencerebralamyloidangiopathyandinsomniabasedonbioinformaticsandexperimentalvalidation
AT kaigao explorationofcommonpathogenicgenesbetweencerebralamyloidangiopathyandinsomniabasedonbioinformaticsandexperimentalvalidation
AT wenjunhe explorationofcommonpathogenicgenesbetweencerebralamyloidangiopathyandinsomniabasedonbioinformaticsandexperimentalvalidation
AT pengpengniu explorationofcommonpathogenicgenesbetweencerebralamyloidangiopathyandinsomniabasedonbioinformaticsandexperimentalvalidation
AT chanzhang explorationofcommonpathogenicgenesbetweencerebralamyloidangiopathyandinsomniabasedonbioinformaticsandexperimentalvalidation
AT yunancheng explorationofcommonpathogenicgenesbetweencerebralamyloidangiopathyandinsomniabasedonbioinformaticsandexperimentalvalidation
AT yushengli explorationofcommonpathogenicgenesbetweencerebralamyloidangiopathyandinsomniabasedonbioinformaticsandexperimentalvalidation